Side Effects & Risks

7-OH and Mental Health: Anxiety, Depression, Mood

The relationship between 7-hydroxymitragynine (7-OH), a primary active compound in kratom, and mental health conditions such as anxiety, depression, and mood disorders is complex and not fully understood. While some individuals report using kratom for its perceived mood-altering effects, scientific research on 7-OH's direct impact on mental health is still emerging and often contradictory. It's crucial for individuals experiencing mental health challenges to seek professional medical advice.

Medically reviewed · Evidence-basedBy Benjamin Zohar, NCACIP · Reviewed by Brandon McNally, RNPublished · Updated · Last reviewed

What is 7-Hydroxymitragynine (7-OH)?

7-Hydroxymitragynine (7-OH) is one of the primary psychoactive alkaloids found in the kratom plant (Mitragyna speciosa). While kratom contains many compounds, 7-OH is often considered to be a potent contributor to some of the plant's effects, particularly those related to opioid receptors in the brain. Its concentration in kratom can vary significantly.

Research into 7-OH is ongoing, aiming to understand its pharmacological profile, including its potential effects on the central nervous system. It's important to differentiate between the effects of isolated 7-OH and the full spectrum of compounds present in the kratom plant, as they may not be identical.

7-OH and Anxiety

Anecdotal reports suggest that some individuals use kratom, and by extension 7-OH, to manage symptoms of anxiety. They may describe feelings of relaxation or reduced stress. However, scientific evidence supporting the use of 7-OH or kratom as an effective or safe long-term treatment for anxiety disorders is limited and inconclusive.

Conversely, some individuals report experiencing increased anxiety, agitation, or panic attacks, especially with higher doses or during withdrawal from kratom. This highlights the unpredictable nature of its effects and the potential for adverse mental health outcomes. Self-medicating anxiety with substances like kratom or 7-OH can mask underlying issues and delay appropriate treatment.

7-OH and Depression

Similar to anxiety, some users report using kratom for its perceived mood-lifting or antidepressant effects. The interaction of 7-OH with opioid receptors might contribute to temporary feelings of euphoria or well-being. However, there is no robust clinical evidence to support the use of 7-OH or kratom as a treatment for clinical depression.

Long-term or heavy use of kratom can potentially worsen depressive symptoms or lead to new onset depression, particularly during periods of withdrawal. Relying on substances for mood regulation can prevent individuals from addressing the root causes of their depression through evidence-based therapies and professional support.

Potential Risks and Withdrawal Effects on Mood

Regular use of kratom, which contains 7-OH, can lead to physical dependence. When dependence occurs, reducing or stopping use can trigger withdrawal symptoms that significantly impact mental health and mood. These symptoms can be distressing and may include:

It is crucial to understand that these withdrawal symptoms can exacerbate pre-existing mental health conditions or create new ones, making recovery more challenging without professional guidance.

  • Severe anxiety and panic
  • Depression and anhedonia (inability to feel pleasure)
  • Irritability and agitation
  • Mood swings
  • Insomnia and disturbed sleep patterns

Seeking Professional Help

If you are experiencing mental health challenges such as anxiety or depression, or if you are struggling with substance use, it is vital to seek help from qualified healthcare professionals. Self-medicating with substances like kratom or 7-OH can be dangerous and may delay effective treatment.

Mental health conditions are treatable, and a healthcare provider can offer an accurate diagnosis, recommend appropriate therapies, and provide support for safe and effective recovery. Resources are available to help you navigate these challenges.

Frequently Asked Questions

Author

Benjamin Zohar, NCACIP

Nationally Certified Advanced Clinical Intervention Professional (NCACIP) · NAADAC Member · ISSUP Network Moderator

Benjamin Zohar is an addiction recovery professional, NAADAC member, and founder of Intervention New York (Intervention NY). A Nationally Certified Advanced Clinical Intervention Professional (NCACIP), he operates a statewide network of treatment navigation, placement, and crisis intervention services across New York, including the Hudson Valley Addiction Treatment Center, Long Island Addiction Treatment Resources, and Every1 Center. He specializes in clinical placement, structured family and executive interventions, and benefits navigation. As an ISSUP Network Moderator, he leads the Integrated Recovery & Intervention Education Network (IRIEN) and authors practical guides and peer-reviewed articles on emerging substance use threats. He also maintains active advocacy membership with the National Alliance on Mental Illness (NAMI).

Medically Reviewed By

Brandon McNally, RN

Registered Nurse (RN) · Medical Reviewer

Registered nurse who reviews clinical content for medical accuracy, ensuring information on 7-OH and kratom dependence, withdrawal, and treatment reflects current evidence-based standards.

References

  1. NIMH — Depression
  2. NIMH — Anxiety Disorders
  3. PubMed — kratom mental health mood
  4. NIDA — Comorbidity: Substance Use & Mental Illness

Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions about a medical condition or substance use. If you are experiencing a medical emergency, call 911.

Related Articles

Call 24/7: 1-800-662-4357